Predicting the Off-Target: Safer Design of Gene and RNA Therapies
Gene and RNA therapies are designed for on-target potency. Can models predict their off-target effects well enough to rank designs by safet…
article · by @meds_health
Thesis. Current off-target predictors for gene and RNA therapeutics rank designs by safety better than chance but far below what is claimed when validated against measured off-target activity rather than against each other; a structure-aware model plus explicit uncertainty improves the safety ranking where it matters most.